BioSpace News Archive

Genetown

ObsEva SA Announces that Shareholders Approved all Board Proposals at its 2021 Annual General Meeting held on May 28, 2021

ObsEva SA, a biopharmaceutical company developing and commercializing novel therapies to improve women’s reproductive health, announced that shareholders approved all Board proposals at its 2021 Annual General Meeting held on May 28, 2021.

May 31, 2021
·
2 min read
Basilea provides updates on efficacy data with derazantinib in bile duct cancer and on ongoing clinical programs in urothelial and gastric cancer

An updated analysis shows further improvement of progression-free survival, disease control rate and objective response rate in the cohort of FGFR2 gene fusion-positive patients with bile duct cancer (iCCA) in FIDES-01 study

May 31, 2021
·
12 min read
GenSight Biologics to Host a Key Opinion Leader Webinar on the Nature Medicine Case Report: Visual Recovery after GS030 Optogenetic Treatment

GenSight Biologics, a biopharma company focused on developing and commercializing innovative gene therapies for retinal neurodegenerative diseases and central nervous system disorders, announced that it will host a Key Opinion Leader call on June 4, 2021 from 8:00 am to 9:00 am EDT.

May 31, 2021
·
6 min read
Samsung Biologics to add mRNA vaccine drug substance manufacturing suite to expand portfolio of services

Samsung Biologics, a global leading CDMO, will add mRNA vaccine DS production capability to its existing facility by the first half of 2022

May 31, 2021
·
2 min read
Business

Microbix Announces Quality Products Distribution AgreementAppointment of SDT Molecular of Singapore

Microbix Biosystems Inc., a life sciences innovator and exporter, announces the appointment of SDT Molecular Pte Ltd as distributor of Microbix’s quality assessment products for four Asia-Pacific territories.

May 31, 2021
·
5 min read
Business

Braxia Scientific Appoints Dr. David Greenberg to Board of Directors

Braxia Scientific Corp., a research driven clinical platform developing and providing innovative ketamine treatments for persons with depression and related disorders, is pleased to announce it has appointed Dr. David Greenberg to its Board of Directors.

May 31, 2021
·
7 min read
Deals

Newly Acquired VitalHub Subsidiary S12 Solutions Reports Recent Sales Since February 2021

VITALHUB CORP. is pleased to report that newly acquired subsidiary, S12 Solutions, has achieved significant market penetration since February 2021.

May 31, 2021
·
4 min read
Theratechnologies Hires Vice President, Human Resources

Theratechnologies Inc., a biopharmaceutical company focused on the development and commercialization of innovative therapies, is pleased to announce that Mr. André Dupras is joining the Company as Vice President, Human Resources.

May 31, 2021
·
5 min read
Kailo Medical Integrates with Medo AI to Standardize Thyroid Ultrasound Practices

Kailo Medical, a healthcare technology company with products that streamline structured reporting in the hospital setting, announces its integration with Medo, an Artificial Intelligence company dual-headquartered in Singapore and Edmonton.

May 31, 2021
·
2 min read
PENTAX Medical and Vedkang Establish Endoscopic Therapeutics Joint Venture

PENTAX Medical and Jiangsu Vedkang Medical Science and Technology Co., Ltd announced the establishment of a joint venture- PENTAX Medical Therapeutics Co., Ltd. to develop single-use therapeutics products in the field of flexible medical endoscopy.

May 31, 2021
·
4 min read